CURE magazine

Bewilderment. That's the only word I can use to describe how I felt upon reading an article in my daily newspaper this morning (Yes, I still read the daily paper). The story reported on an influential federal task force's recommendation that women have fewer mammograms. ...

A few blogs ago I told you about my discussion with Otis Brawley, MD, the chief medical officer of ACS and his message that we have to use what we know to prevent cancer and be well, and it comes down ...

MRI of the breast has the greatest potential, compared with digital mammography or whole-breast ultrasound, for detecting cancers missed by film screen mammogram, study findings indicate.

Women with dense breasts who have had lumpectomies for breast cancer are at a higher risk of a recurrence, according to a new study.

This must be the season for drug approvals for rare lymphomas--an early Christmas gift to many patients suffering from a rare blood cancer.

In women treated for small (1 cm or less), node-negative breast cancers, HER2 positivity is strongly linked to recurrence and poorer disease-free survival, according to the results of two studies reported in the November 2nd online issue of the Journal of Clinical Oncology.

Men who regularly get moderate exercise may have a lower risk of developing prostate cancer -- including aggressive, fast-growing tumors, a new study finds.

Last week I met with 30 cancer survivors at Gilda's Club North Texas to talk about survivorship, the time after treatment ends when we have to find our life again. We spend lots of time and energy on getting ...

Patients with metastatic colorectal cancer (mCRC) enrolled in clinical trials have a better prognosis than do such patients in general, according to Scandinavian researchers.

Low total cholesterol may be a sign of cancer rather than a cause, as some researchers have suggested, and men who have low cholesterol actually have a lower risk of developing high-risk prostate cancer, two teams reported on Tuesday.

Each year, the American Society of Clinical Oncology releases a report that pinpoints the top advances in cancer treatment, prevention and screening. This year, ASCO identified 15 key advances in four areas. (The advances were not ranked.)

Cancer advocacy groups, sanofi-aventis US, and show producers have teamed up to offer cancer survivors a free ticket to the taping of Kaleidoscope, a television special to raise awareness for cancers that affect women.

Survivors of childhood CNS tumors have consistently been shown to be at risk for residual neurocognitive impairment, and a new study indicates that in many cases, deficits persist into adulthood.